Related Experiment Video
Updated: Feb 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
Yang Yang-Hartwich1, Roslyn Tedja1, Cai M Roberts2
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.
Abstract:
Epithelial-mesenchymal transition (EMT) is a critical process involved in cancer metastasis and chemoresistance. Twist1 is a key EMT-inducing transcription factor, which is upregulated in multiple types of cancers and has been shown to promote tumor cell invasiveness and support tumor progression. Conversely, p53 is a tumor suppressor gene that is frequently mutated in cancers. This study demonstrates the ability of wild-type (WT) p53 to promote the degradation of Twist1 protein. By forming a complex with Twist1 and the E3 ligase Pirh2, WT p53 promotes the ubiquitination and proteasomal degradation of Twist1, thus inhibiting EMT and maintaining the epithelial phenotype. The ability of p53 to induce Twist1 degradation is abrogated when p53 is mutated. Consequently, the loss of p53-induced Twist1 degradation leads to EMT and the acquisition of a more invasive cancer phenotype.Implication: These data provide new insight into the metastatic process at the molecular level and suggest a signaling pathway that can potentially be used to develop new prognostic markers and therapeutic targets to curtail cancer progression.
Insights
Wild-type p53 degrades Twist1 protein, inhibiting cancer metastasis. Loss of this p53 function in mutated cancers promotes tumor invasiveness and progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Epithelial-mesenchymal transition (EMT) drives cancer metastasis and chemoresistance.
- Twist1 is a key transcription factor promoting EMT, invasiveness, and tumor progression.
- p53, a tumor suppressor, is frequently mutated in cancers.
Purpose of the Study:
- To investigate the role of wild-type p53 in regulating Twist1 protein.
- To elucidate the mechanism by which p53 affects Twist1 during cancer progression.
Main Methods:
- Investigated the interaction between wild-type p53, Twist1, and the E3 ligase Pirh2.
- Assessed the ubiquitination and proteasomal degradation of Twist1.
- Examined the impact of p53 mutation on Twist1 degradation and EMT.
Main Results:
- Wild-type p53 forms a complex with Twist1 and Pirh2, promoting Twist1 ubiquitination and degradation.
- p53-mediated Twist1 degradation inhibits EMT and maintains the epithelial phenotype.
- Mutated p53 loses the ability to induce Twist1 degradation, leading to EMT.
Conclusions:
- p53 acts as a crucial regulator of Twist1 stability, thereby controlling EMT.
- The loss of p53's ability to degrade Twist1 contributes to cancer cell invasiveness and progression.
- This pathway presents potential therapeutic targets for inhibiting cancer metastasis.
Related Concept Videos
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The Eukaryotic Promoter Region
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...

